Source comparison
How to Use PT-141 for Erectile Function Protocol: Comparison
Mechanism MC4R receptor agonist in hypothalamus—activates central arousal pathways PDE5 inhibitor—blocks cGMP degradation to enhance nitric oxide-mediated vasodilation PDE5 inhibitor—same mechanism as sildenafil, longer half-life PT-141 works on brain pathways
This comparison does not assign a generated winner or score.
- Mechanism
- MC4R receptor agonist in hypothalamus—activates central arousal pathways
- PDE5 inhibitor—blocks cGMP degradation to enhance nitric oxide-mediated vasodilation
- PDE5 inhibitor—same mechanism as sildenafil, longer half-life
- PT-141 works on brain pathways; PDE5 inhibitors work on vascular tone—fundamentally different failure points
- Onset
- 60–90 minutes subcutaneous injection
- 30–60 minutes oral
- 30–120 minutes oral
- PT-141 requires earlier planning but doesn't depend on food intake
- Duration
- 6–24 hours (individual variation)
- 4–6 hours
- 24–36 hours
- Tadalafil offers longest window; PT-141 offers unpredictable but often prolonged arousal restoration
- Efficacy in vascular ED
- Moderate—bypasses vascular damage but doesn't repair it
- High—if nitric oxide signaling intact
- PT-141 superior when vascular or neurological damage present
- Side effects
- Nausea (30–40%), flushing (15–20%), headache (10%)
- Headache (16%), flushing (10%), nasal congestion (4%)
- Headache (11%), dyspepsia (7%), back pain (6%)
- PT-141 nausea is dose-limiting; PDE5 inhibitors generally better tolerated
- Contraindications
- Uncontrolled hypertension (>160/100 mmHg)
- Nitrate medications (absolute), severe cardiovascular disease
- PT-141 safer in men on nitrates but requires blood pressure monitoring